PubMed · 1992 · 48 citations · 16 references
MedicineOncologyPediatricsChemotherapyPediatric Clinical PharmacologyPediatric OncologyChemotherapy Toxicity ManagementInfant PharmacotherapyPediatric ChemotherapyChemotherapy Toxicity MonitoringChemotherapy-related ToxicityCumulative Dose EffectsGlomerular Filtration Rate MeasurementLong-term MorbidityMedian Toxic DosePediatric Chemotherapy AdministrationPediatric Oncology Pharmacology
UNLABELLED: The tolerance to and toxicity of cisplatin treatment was retrospectively studied in 30 infants. A total of 191 courses were given with a median of six per child and a median cumulative dose of 400 mg m-2. Electrolyte disturbances were noted in 15/23 infants (38:144 courses): hypomagnesaemia, which was dose related, in 10/23 (25/144 courses), hyponatraemia in 6/23 (7:144 courses), hypercalcaemia in 4/23 (6/144 courses), and hypocalcaemia in 3/23 (4/144 courses). Seizures occurred in two infants. Vomiting followed 31/191 courses and neutropenic febrile episodes 23/191 courses. Median survival is 6 years 1 month. Six children have died of progressive malignancy. Glomerular filtration rate was less than 80 ml min-1 per 1.73 m2 in 15/29 children, at or within a month of the end of treatment; of ten retested at follow-up, eight had increased to more than 80 ml min-1 per 1.73 m2 (P = 0.027). High-frequency hearing loss was observed in 10/28 children, but was only significant in five (four grade 2 and one grade 3). IN CONCLUSION: the long-term toxicity of cisplatin in infants, at this dose range and schedule, is no more severe than in older children.
16
Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA.
C Chantler, E.S. Garnett, V. Parsons et al. · PubMed · 1969 · 438 citations
Cisplatin ototoxicity in children: A practical grading system
Penelope Brock, Susan Bellman, Elizabeth C. Yeomans et al. · Medical and Pediatric Oncology · 1991 · 281 citations
Medicine, Oncology, Otolaryngology +17